Internal Medicine · Houston, TX
NPI
1487705034
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
4910 Telephone Rd
Houston, TX, 77087
Phone (713) 641-3900
Groups this clinician bills Medicare through
Medicare paid, 2024
$166K
5,574 services
Medicare patients, 2024
177
Average age 72
Drug cost, 2024
$5.2M
37,616 prescriptions
Company payments, 2025
$4,573
From 37 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Murtaza Mussaji was code 99421 (office/outpatient services), 1,720 times for 58 patients. In total Murtaza Mussaji billed 5,574 services in 60 codes, and Medicare paid $166K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-05-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99421 Office/Outpatient Services | Office | 1,720 | 58 | $11.31 | $19K |
| 99214 Office E&M - Established | Office | 466 | 151 | $84.22 | $39K |
| 99457 E&M - Miscellaneous | Office | 438 | 60 | $36.85 | $16K |
| 99458 E&M - Miscellaneous | Office | 371 | 51 | $29.63 | $11K |
| 99454 E&M - Miscellaneous | Office | 309 | 41 | $35.79 | $11K |
| 99423 E&M - Miscellaneous | Office | 245 | 14 | $35.69 | $8,743 |
| 99213 Office E&M - Established | Office | 153 | 73 | $63.79 | $9,760 |
| 93000 Electrocardiogram | Office | 107 | 104 | $8.53 | $912 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 92 | 92 | $128.59 | $12K |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 86 | 86 | $18.61 | $1,600 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 79 | 79 | $18.58 | $1,468 |
| 96372 Injection Administration | Office | 74 | 34 | $9.94 | $736 |
| G0008 Administration of influenza virus vaccine | Office | 73 | 72 | $31.37 | $2,290 |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 68 | 34 | $24.33 | $1,654 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 64 | 21 | $0.07 | $4.72 |
By year: 2022 $267K for 8,844 services; 2023 $181K for 6,937 services; 2024 $166K for 5,574 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87804 Immunoassay | 64 | 25 | $15.71 | $1,006 |
| 87811 Immunoassay | 32 | 25 | $39.28 | $1,257 |
Medicare prescription drug claims, 2024
In 2024, the drug Murtaza Mussaji prescribed most often to Medicare patients was Atorvastatin Calcium, with 2,203 prescriptions and refills. In total Murtaza Mussaji wrote 37,616 Medicare prescriptions that cost $5.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 2,203 | 6,268 | 677 | $23K |
| Amlodipine Besylate Generic | 1,875 | 5,371 | 574 | $10K |
| Levothyroxine Sodium Generic | 1,289 | 3,660 | 357 | $11K |
| Gabapentin Generic | 1,247 | 3,276 | 433 | $22K |
| Rosuvastatin Calcium Generic | 1,072 | 3,091 | 320 | $19K |
| Losartan Potassium Generic | 1,007 | 2,869 | 300 | $11K |
| Metformin Hcl Generic | 899 | 2,569 | 270 | $5,434 |
| Lisinopril Generic | 894 | 2,551 | 275 | $5,692 |
| Tamsulosin Hcl Generic | 859 | 2,524 | 278 | $12K |
| Metoprolol Succinate Generic | 838 | 2,359 | 251 | $13K |
| Metformin Hcl Er Metformin Hcl | 827 | 2,349 | 265 | $7,560 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 819 | 951 | 213 | $24K |
| Furosemide Generic | 734 | 1,983 | 252 | $3,366 |
| Ozempic Semaglutide | 730 | 1,047 | 139 | $912K |
| Trazodone Hcl Generic | 695 | 1,891 | 228 | $5,033 |
Brand drugs: 5,349 claims; generic drugs: 31,934 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Murtaza Mussaji $4,573 ($4,573 in general payments such as food, travel and fees) from 37 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $939.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 27 | $939 |
| Novo Nordisk Inc NVO | 23 | $808 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 15 | $507 |
| Madrigal Pharmaceuticals MDGL | 3 | $306 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 6 | $231 |
| GlaxoSmithKline, LLC. GSK | 13 | $225 |
| Dexcom, Inc. DXCM | 9 | $194 |
| Amgen Inc. AMGN | 5 | $193 |
| Merck Sharp & Dohme LLC MRK | 2 | $138 |
| Axsome Therapeutics, Inc. AXSM | 2 | $127 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.